Browse Related Topics For:

Pharmaceutical Industry

1041
Prescription Drugs
979
FDA
960
Patents
696
Pharmaceutical Patents
594
Patent Litigation
533
Generic Drugs
473
Patent Infringement
408
Medical Devices
399
Biosimilars
300
Healthcare
295
ANDA
230
SCOTUS
225
Biotechnology
200
Hatch-Waxman
197
Manufacturers
181
BPCIA
180
Popular
170
Biologics
169
Drug Pricing
162
Life Sciences
158
FTC
158
Health Care Providers
153
Off-Label Promotion
146
CMS
144
HHS
143
EU
140
Medicare
138
Pharmacies
135
Physicians
131
Affordable Care Act
125
China
123
Medicaid
115
DOJ
112
Hospitals
111
Clinical Trials
109
Amgen
109
Section 340B
108
False Claims Act (FCA)
108
Sandoz
106
FDCA
106
Teva Pharmaceuticals
102
FDA Approval
100
First Amendment
99
Mylan Pharmaceuticals
94
Sandoz v Amgen
92
Preemption
91
Enforcement Actions
91
Off-Label Use
88
Compliance
88
Patent Trial and Appeal Board
87
Class Action
87
SEC
86
Inter Partes Review (IPR) Proceeding
85
Appeals
85
Patent-in-Suit
80
Claim Construction
80
HRSA
78
Labeling
73
Actavis Inc.
73
Marketing
73
Novartis
71
FCPA
71
Pfizer
71
USPTO
70
Failure To Warn
70
OIG
69
Intellectual Property Protection
68
Antitrust Litigation
68
Corporate Counsel
67
Obviousness
67
Reverse Payment Settlement Agreements
67
UK
66
Pay-For-Delay
64
Draft Guidance
63
GlaxoSmithKline
62
Patent-Eligible Subject Matter
61
FTC v Actavis
61
Sunshine Act
59
Trump Administration
58
Australia
56
Anti-Kickback Statute
56
Bribery
56
Teva v Sandoz
55
Apotex
54
Settlement
52
Orphan Drugs
52
Preliminary Injunctions
51
Patent Dance
50
Advertising
50
Civil Monetary Penalty
50
De Novo Standard of Review
50
Health Insurance
50
Medical Research
50
Personal Jurisdiction
49
Amarin
49
Infringement
49
Prior Art
48
AstraZeneca
48
Clear Error Standard
48
Federal Rules of Civil Procedure
48
Free Speech
48
Reporting Requirements
47
Medicare Part D
47
Patent Applications
47
Warning Labels
47
Whistleblowers
45
Comment Period
45
PHRMA
44
Fraud
43
Disclosure Requirements
43
Research and Development
42
21st Century Cures Initiative
41
Commercial Marketing
41
Financial Sector
41
Merck
41
Misbranding
40
AbbVie
40
Bayer
39
Covered Entities
39
Criminal Prosecution
38
Canada
38
Legislative Agendas
38
Mergers
38
Multidistrict Litigation
38
Negligence
38
Opioid
38
Proposed Legislation
38
Summary Judgment
37
Patent Invalidity
36
Acquisitions
36
Final Rules
36
Notice Requirements
36
Product Defects
35
America Invents Act
35
Eli Lilly
35
Hart-Scott-Rodino Act
35
Pending Legislation
35
Regulatory Standards
34
Competition
34
Declaratory Judgments
34
Design Defects
34
Drug Safety
34
European Medicines Agency (EMA)
34
Healthcare Reform
34
Sherman Act
33
Antitrust Provisions
33
Dismissals
33
White Collar Crimes
32
Drug Compounding
32
HIPAA
32
Hospira
32
Qui Tam
32
Trademarks
31
Johnson & Johnson
31
Kickbacks
31
Public Health
30
Cancer
30
Causation
30
Enforcement
30
Healthcare Facilities
29
Anti-Corruption
29
Bristol-Myers Squibb
29
Commercial Speech
29
European Commission
29
Proposed Regulation
29
Transparency
28
Abbott Laboratories
28
Anti-Competitive
28
DNA
28
EPA
28
Innovation
28
Insurance Industry
28
Jurisdiction
28
Product Labels
28
Safe Harbors
28
Watson Pharmaceuticals
27
Antitrust Violations
27
Janssen Pharmaceuticals
27
NIH
26
Allergan Inc
26
Drug & Alcohol Abuse
26
Expert Testimony
26
False Advertising
26
GPOs
26
Learned Intermediary
25
Financial Markets
25
Imports
25
Motion to Dismiss
25
Regulatory Oversight
24
Corruption
24
Cybersecurity
24
DaimlerChrysler v Bauman
24
Gilead Sciences
24
Healthcare Fraud
24
Mass Tort Litigation
24
Mental Health
24
New Guidance
24
Standing
23
Biologics Price Competition and Innovation Act of 2009
23
Discovery
23
Product Hopping
23
Securities Fraud
23
Valeant
22
Birth Defects
22
Insider Trading
22
Medicare Part B
22
Misrepresentation
22
PLIVA v Mensing
22
Public Comment
21
aBLA
21
Class Certification
21
Disgorgement
21
Hazardous Waste
21
Trans-Pacific Partnership
21
UK Brexit
20
Ethics
20
FFDCA
20
New Legislation
20
Patients
20
Pleading Standards
20
Scientific Research
20
Strict Liability
20
Wrongful Death
19
Damages
19
Genentech
19
General Jurisdiction
19
Licenses
19
Patent Reform
19
Russia
19
Takeda Pharmaceuticals
19
Technology Sector
18
Attorney Generals
18
Audits
18
Biopharmaceutical
18
Caronia
18
Chief Compliance Officers
18
Citizen Petitions
18
DEA
18
Duty to Warn
18
Hedge Funds
18
India
18
Lanham Act
18
Mutual Pharmaceuticals v Bartlett
18
Professional Conferences
18
Public Health Service Act
18
Securities Litigation
18
Social Media
18
Specific Jurisdiction
17
Antitrust Investigations
17
Banking Sector
17
Congressional Investigations & Hearings
17
France
17
Medical Malpractice
17
On-Sale Bar
17
Orange Book
17
Prescription Drug Coverage
17
RCRA
17
Side Effects
17
Trade Secrets
16
Barack Obama
16
Evidence
16
Exports
16
Innovator Liability
16
Intellectual Property Litigation
16
License Agreements
16
Monopolization
16
Omnicare
16
Penalties
16
Price-Fixing
16
Product Exclusivity
16
Putative Class Actions
16
Stocks
16
Supply Chain
16
Technology
16
Unfair Competition
16
Warner Chilcott
16
Yates Memorandum
15
AMP v Myriad
15
CA Supreme Court
15
Celltrion
15
Cephalon
15
Certiorari
15
Data Protection
15
Drug Approvals
15
Final Guidance
15
Mayo v. Prometheus
15
Myriad
15
Open Payments
15
Personalized Medicine
15
Post-Grant Review
15
Private Equity
15
Regulatory Agenda
15
Substance Abuse
15
Warning Letters
15
Wells Fargo
14
Administrative Procedure Act
14
Automotive Industry
14
Cartels
14
Distributors
14
DSCSA
14
Forum Shopping
14
Genetic Materials
14
Government Investigations
14
Joint Venture
14
OMB
14
Par Pharmaceutical
14
Pregnancy
14
Relators
14
Securities
14
Trade Agreements
14
World Health Organization
14
Wyeth
13
21st Century Cures Act
13
CAFA
13
Controlled Substances
13
Copyright
13
Endo Pharmaceuticals
13
Fee-for-Service
13
Inadequate Warning
13
Induced Infringement
13
Medicare Advantage
13
Professional Misconduct
13
Rebates
13
Risk Management
13
Settlement Agreements
13
Telemedicine
13
Theranos
13
UK Competition and Markets Authority (CMA)
13
Venture Capital
12
Banks
12
Breach of Contract
12
Competition Authorities
12
DQSA
12
Energy Sector
12
Expert Witness
12
Federal Contractors
12
Foreign Investment
12
IP License
12
Japan
12
Medtronic
12
Oil & Gas
12
Omnicare v Laborers District Council
12
PHI
12
Physician Medicare Reimbursements
12
Product Recalls
12
Publicly-Traded Companies
12
Reimbursements
12
REMS
12
Repeal
12
RICO
12
Risk Assessment
12
Section 11
12
Social Networks
12
Startups
12
Teaching Hospitals
12
Ukraine
12
Wholesale
11
Breach of Warranty
11
Bristol-Myers Squibb Co v Superior Court of California - San Francisco County
11
Co-payments
11
Confidential Information
11
Data Collection
11
Diagnostic Tests
11
Dietary Supplements
11
DOL
11
Drug Distribution
11
Foreign Corporations
11
Fraudulent Joinder
11
GAO
11
Generic
11
Health Information Technologies
11
Human Genes
11
Injunctions
11
Injunctive Relief
11
Interchangeability
11
Investors
11
IPO
11
Italy
11
Manufacturing Defects
11
Material Misstatements
11
MCOs
11
Mexico
11
Misleading Statements
11
Nexium
11
OFAC
11
Otsuka Pharmaceutical
11
Patent Term Extensions
11
Payment Records
11
Petition for Writ of Certiorari
11
Presidential Elections
11
Public Disclosure
11
Public Meetings
11
Retailers
11
Sanctions
11
Sanofi-Aventis
11
Securities Act of 1933
11
Software
11
Stark Law
11
Subject Matter Jurisdiction
11
Young Lawyers
10
3D Printing
10
CDC
10
Chemicals
10
CHIP
10
Department of Health
10
Durable Medical Equipment
10
En Banc Review
10
Exclusivity
10
Financial Conduct Authority (FCA)
10
Financial Institutions
10
Genetic Testing
10
Genzyme
10
Google
10
Hackers
10
Long Term Care Facilities
10
Managed Care Contracts
10
Medical Supplies
10
Merger Agreements
10
Ministry of Health
10
New Regulations
10
Nurses
10
OxyContin
10
Patent Term Adjustment
10
Physician Payments
10
Registration Requirement
10
Securities Exchange Act
10
Tax Credits
10
Telecommunications
10
Unfair or Deceptive Trade Practices
10
Vaccinations
9
ACOs
9
Adverse Events
9
Arbitration
9
Boehringer
9
Brand
9
Brazil
9
China FDA
9
Clinical Laboratories
9
CLS Bank v Alice Corp
9
Continuing Medical Education
9
Controlled Substances Act
9
Corporate Culture
9
Cross-Border Transactions
9
Data Breach
9
Defense Strategies
9
Export Controls
9
Federal Budget
9
Federal Funding
9
Fiduciary Duty
9
Food Manufacturers
9
Healthcare Costs
9
Illegal Drugs
9
Informed Consent
9
Legislative Committees
9
Medicaid Expansion
9
Member State
9
Negligent Misrepresentation
9
Nursing Homes
9
Omnibus Guidance
9
Pain Management
9
Private Right of Action
9
Punitive Damages
9
RanBaxy
9
Registration Statement
9
Reverse Payments
9
RMBS
9
Roxane Laboratories
9
Rule-of-Reason Analysis
9
Rulemaking Process
9
Shareholder Litigation
9
Standard of Review
9
Statute of Limitations
9
Strategic Enforcement Plan
9
Value-Based Purchasing
9
Websites
9
Zoloft
8
Anti-Monopoly
8
Antitrust Division
8
Aviation Industry
8
BRCA
8
CFDA
8
Conflicts of Interest
8
Corporate Integrity Agreement
8
Deferred Prosecution Agreements
8
Due Diligence
8
EEA
8
Employee Benefits
8
Environmental Policies
8
Fiduciary Rule
8
FINRA
8
First-to-File
8
FOIA
8
Fraud and Abuse
8
Germany
8
Good Faith
8
Guidance Update
8
Hiring & Firing
8
Interpretive Rule
8
Inventions
8
Inventors
8
Investigational New Drug Application (IND)
8
Ireland
8
IRS
8
Joinder
8
Marketing Authorization Application
8
Martin Shkreli
8
MedPAC
8
Mensing
8
Multinationals
8
Noninfringement
8
Obama Administration
8
OCR
8
Patient Assistance Programs
8
Permanent Injunctions
8
PHSA
8
Public Hearing
8
Public Offerings
8
Recordkeeping Requirements
8
Remand
8
Royalties
8
Safe Drug Disposal
8
Scienter
8
Securities Violations
8
Shareholders
8
USDA
8
Written Descriptions
8
WTO
7
Administrative Proceedings
7
Africa
7
Agricultural Sector
7
Allergan v Sandoz
7
Amgen v Sandoz
7
Auto Manufacturers
7
Bank Accounts
7
Biogen Idec
7
Burden of Proof
7
C-Suite Executives
7
Coherus
7
Daubert Standards
7
Diagnostic Method
7
Due Process
7
False Statements
7
Fines
7
Food Labeling
7
Home Health Care
7
Innovation Act
7
Internal Controls
7
International Harmonization
7
Inversion
7
Investment
7
Jazz Pharmaceuticals
7
Jury Verdicts
7
Licensing Rules
7
Limelight v Akamai
7
Meals-Gifts-and Entertainment Rules
7
Medical Marijuana
7
Monsanto
7
Myriad-Mayo
7
New Zealand
7
OECD
7
Pleadings
7
Premerger Notifications
7
Radiopharmaceuticals
7
Referendums
7
Sanofi
7
Skilled Nursing Facility
7
Tariffs
7
TCPA
7
The Clayton Act
7
Third-Party
7
Trademark Infringement
7
TRIPS Agreement
7
Twombly/Iqbal Pleading Standard
7
Universal Health Services Inc v United States ex rel Escobar
7
User Fees
7
Vacated
7
Wage and Hour
7
Walgreens
7
Yahoo!
6
AIDS
6
Anti-Bribery
6
Applications
6
Attorney-Client Privilege
6
Australian Patent Office
6
Bayh-Dole Act
6
BIS
6
Black Box Warnings
6
Bonds
6
Capital Raising
6
CETA
6
Choice-of-Law
6
Compensatory Damages
6
Conspiracies
6
Consumer Fraud
6
Corporate Misconduct
6
Corporate Taxes
6
Cosmetics
6
Cost-Sharing
6
Covered Recipients
6
Cross-Border
6
Cross-Selling
6
Cyber Attacks
6
Data Security
6
Data-Sharing
6
Databases
6
Daubert Ruling
6
Declaratory Relief
6
Digital Health
6
Disclosure
6
Discount Pricing
6
Dodd-Frank
6
E-Commerce
6
Economic Development
6
Emerging Growth Companies
6
Exclusive Dealing Agreements
6
Facebook
6
FCC
6
Federal Jurisdiction
6
Federal Register
6
Food and Drug Administration Amendments Act (FDAAA)
6
Foreign Official
6
Forest Laboratories
6
Forum
6
FTC Act
6
Funding
6
General Motors
6
Guilty Pleas
6
Health Insurance Exchanges
6
Hoffman LaRoche
6
Hospital Mergers
6
Initial Public Offerings
6
Inspections
6
Investigational New Drug procedures (IND)
6
Iran
6
JPMorgan Chase
6
License Applications
6
Lipitor
6
Litigation Strategies
6
Merger Controls
6
Method Claims
6
Mobile Apps
6
Mortgages
6
NAFTA
6
Negotiations
6
OPDP
6
Outsourcing
6
Over-the-Counter Sales
6
Patent Trolls
6
Patient Privacy Rights
6
PDUFA
6
Pharmaceutical Reverse Distributors
6
Price Gouging
6
Provider Payments
6
Public Health Insurance Marketplace
6
Real Party in Interest
6
Reversal
6
Samsung
6
Samsung Bioepis
6
Secretary of HHS
6
Section 101
6
SFDA
6
Shire Development v Watson
6
Small Business
6
South Korea
6
Standard Essential Patents
6
State and Local Government
6
Statement of Opinion
6
Subpoenas
6
Suppliers
6
Toxic Exposure
5
Abuse of Dominance
5
Abuse of Process
5
Admissible Evidence
5
ALJ
5
American Medical Association
5
Amicus Briefs
5
Anticompetitive Behavior
5
Article III
5
Asia
5
Australian Competition and Consumer Commission
5
Big Data
5
Bodily Injury
5
Celebrity Endorsements
5
CEOs
5
CGMP
5
Chevron Deference
5
Cipro
5
Classen Immunotherapies
5
Commercial Bankruptcy
5
Competition Act
5
Construction Industry
5
Consumer Lenders
5
Criminal Conspiracy
5
CVS
5
Department of Veterans Affairs
5
Deutsche Bank
5
Direct Infringement
5
Dispute Resolution
5
Diversity Jurisdiction
5
Domestic Violence
5
Dormant Commerce Clause
5
Elder Abuse
5
Employer Group Health Plans
5
Enablement Inquiries
5
Executive Orders
5
FBI
5
FD&C Act
5
FDA Warning Letters
5
Federal Pilot Programs
5
Federal Rule 12(b)(6)
5
Fifth Amendment
5
Food Safety
5
Foreign Manufacturers
5
Forum Selection
5
Fourteenth Amendment
5
General Electric
5
Goldman Sachs
5
Good Clinical Practices
5
Hazardous Substances
5
HCEI
5
HITECH
5
Hospice
5
Indictments
5
Interest Rate Adjustments
5
Interest Rates
5
International Arbitration
5
Internet
5
ITC
5
JAMA
5
Jury Instructions
5
Kaiser Permanente
5
Likelihood of Confusion
5
Materiality
5
Medicaid Reimbursements
5
Medical Reimbursement
5
Medicines and Healthcare Products Regulatory Agency (MHRA)
5
Mootness
5
Motion for Summary Judgment
5
No-AG Agreement
5
Online Advertisements
5
Online Marketplace Lending
5
Overpayment
5
PATENT Act
5
Patent Prosecution
5
Patient Safety
5
Personal Care Products
5
Pharmacist
5
Pre-Merger Filing Requirements
5
Prior Express Consent
5
Privacy Laws
5
PSLRA
5
Regulatory Agencies
5
Regulatory Reform
5
Remedies
5
Removal
5
Retaliation
5
Retirement Plan
5
Risk Mitigation
5
Section 10(b)
5
Sharing Economy
5
Software Developers
5
Solicitor General
5
Spain
5
State of Incorporation
5
Stem cells
5
Subsidies
5
Surveys
5
Telehealth
5
Trade Agreements Act
5
Trade Relations
5
Trademark Registration
5
Trademark Trial and Appeal Board
5
Training
5
Transportation Industry
5
Twitter
5
UK Bribery Act
5
Unions
5
USTR
5
Vendors
5
Veterinary Products
5
Volkswagen
4
23andMe
4
Acquittals
4
Actos
4
Administrative Authority
4
Advisory Committee
4
Aerospace
4
Alzheimer's
4
Amended Legislation
4
Anti-SLAPP
4
Antibiotics
4
Antitrust Conspiracies
4
Antitrust Injuries
4
Apple
4
Applicable Manufacturers
4
Ascertainable Class
4
Attorney's Fees
4
Australian Medical Association
4
Ballot Measures
4
Barclays
4
Best Practices
4
Board of Directors
4
CAFC
4
Calculation of Damages
4
Cardinal Health
4
CMMI
4
Code of Conduct
4
Compulsory Licenses
4
Consent Order
4
Contraceptives
4
Cooperation
4
Counterclaims
4
Counterfeit Drugs
4
Cuba
4
Daiichi Sankyo
4
Dairy Farmers
4
Data Privacy
4
Department of Transportation (DOT)
4
Derivative Suit
4
Divestiture
4
Divided Infringement
4
DMEPOS
4
Doctrine of Equivalents
4
Double Patent
4
Duty of Care
4
Duty to Deal
4
EAR
4
Economic Sanctions
4
EHR
4
Elan Pharmaceuticals
4
ERISA
4
EU Single Market
4
EU-US Privacy Shield
4
Exemptions
4
Failure To Disclose
4
Fair Work Commission
4
FDASIA
4
Federal Reserve
4
Food Recalls
4
Forum Non Conveniens
4
FRAND
4
Fresenius
4
Genetic Markers
4
Global Marketplace
4
Health Canada
4
Hepatitis C
4
HIV
4
Human Rights
4
Implied Preemption
4
Individual Accountability
4
Information Technology
4
Interlocutory Injunctions
4
InterMune
4
Interstate Commerce
4
Investment Adviser
4
Investment Management
4
Job Creation
4
Kim Kardashian
4
Kimble v Marvel Enterprises
4
Laboratory Developed Tests
4
Local Ordinance
4
Marijuana
4
Material Nonpublic Information
4
Medical Records
4
Medicare Access and CHIP Reauthorization (MACRA)
4
Microsoft
4
Middle East
4
Minimum Contacts
4
Mining
4
Misleading Impressions
4
MOFCOM
4
Morgan Stanley
4
Motion To Strike
4
Nanotechnology
4
National Cancer Moonshot
4
NDRC
4
Non-Prosecution Agreements
4
Nutritional Supplements
4
OTC
4
Pain Management Clinics
4
Patent Portfolios
4
Pension Funds
4
Pensions
4
Personal Liability
4
Pharmaceutical Distribution
4
Physician Fee Schedule
4
PMNOC Regulations
4
Policies and Procedures
4
Prejudgment Interest
4
Premiums
4
Proposed Amendments
4
Proximate Cause
4
Public Officials
4
Quality Control Plan
4
Red Notices
4
Retail Market
4
Rule 9(b)
4
Safety Standards
4
Schering-Plough
4
SDN List
4
Sealed Records
4
Section 2
4
Section 337
4
Shareholder Activism
4
Shipping
4
SmithKline Beecham
4
Social Services
4
Solid Waste
4
South Africa
4
STRONG Patents Act
4
Stryker
4
Takeover Bids
4
Tax Reform
4
TFEU
4
The Common Rule
4
Third-Party Relationships
4
Trademark Litigation
4
TRICARE
4
TTIP
4
UAW
4
Uber
4
Universities
4
Utility Patents
4
Value-Based Care
4
Verification Requirements
4
Viagra
4
Webinars
4
Whistleblower Protection Policies
3
510(k) RTA
3
Abuse of Discretion
3
Acquisition Agreements
3
Activist Investors
3
Advisory Opinions
3
Algorithmic Trading
3
Alibaba
3
Ambry
3
Amended Regulation
3
Amgen v Apotex
3
Animal Testing
3
Annual Reports
3
Anticompetitive Agreements
3
Ariosa
3
Asbestos
3
Aurobindo Pharmaceuticals
3
AZ Supreme Court
3
Bank of America
3
Biometric Information
3
Breach of Duty
3
Brokers
3
Cadence Pharmaceuticals Inc.
3
Cadillac Tax
3
Cease and Desist Orders
3
Center for Drug Evaluation and Research (CDER)
3
Certificate of Need
3
CFPB
3
Charles Grassley
3
Children's Products
3
Clear and Convincing Evidence
3
Climate Change
3
Collective Bargaining
3
Columbia
3
Comcast v. Behrend
3
Commerce Clause
3
Commercial General Liability Policies
3
Confidentiality Agreements
3
Congressional Budget Office
3
Congressional Committees
3
Consent
3
Consumer Product Safety Commission (CPSC)
3
Consumer Protection Act
3
Contraceptive Coverage Mandate
3
Contract Disputes
3
Contract Negotiations
3
Conversion
3
Corporate Crimes
3
Corporate Governance
3
Corporate Officers
3
Counterfeiting
3
Country of Origin
3
Coupons
3
Covered Business Method Patents
3
Criminal Investigations
3
Crowdfunding
3
Cuozzo Speed Technologies v Lee
3
Customs
3
DE Supreme Court
3
Debt Ceiling
3
Defense Sector
3
Dentists
3
Depositions
3
Deregulation
3
DHS
3
Direct to Consumer Sales
3
Disciplinary Proceedings
3
Discounts
3
Discrimination
3
Dismissal With Prejudice
3
Drug Testing
3
Drug Wholesaling
3
E-Cigarettes